These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14063015)

  • 21. THE EFFECT OF SEROTONIN AND SEROTONIN ANTAGONISTS ON EXTERNAL PANCREATIC SECRETION IN DOGS.
    HUDOCK JJ; KHENTIGAN A; VANAMEE P; LAWRENCE W
    J Surg Res; 1963 Aug; 3():307-12. PubMed ID: 14051998
    [No Abstract]   [Full Text] [Related]  

  • 22. RELEASE OF THYROIDAL SEROTONIN BY RESERPINE, METHYLDOPA AND GUANETHIDINE.
    MAGUS RD; KRAUSE FW; RIEDEL BE
    Biochem Pharmacol; 1964 Jan; 13():115-7. PubMed ID: 14104922
    [No Abstract]   [Full Text] [Related]  

  • 23. CHEMICAL AND VASCULAR FACTORS IN THE DUMPING SYNDROME.
    JESSEPH JE; HARKINS HN
    Bull Soc Int Chir; 1963; 22():446-50. PubMed ID: 14113482
    [No Abstract]   [Full Text] [Related]  

  • 24. MEDICATION WHICH MAY INHIBIT CARDIOVASCULAR REACTIVITY TO STRESS.
    CHARLEBOIS P; GLEDHILL P
    Can Anaesth Soc J; 1964 May; 11():318-22. PubMed ID: 14161447
    [No Abstract]   [Full Text] [Related]  

  • 25. [BIOGENIC AMINES IN RAT URINE AND BLOOD AFTER SUBLETHAL TOTAL BODY IRRADIATION. 3. THE EFFECT OF ALPHA-METHYLDOPA AND PHENYLACETIC ACID ON THE ABNORMAL PRESENCE OF AUTOGENOUS AMINES AFTER TOTAL BODY IRRADIATION].
    FRANZEN F; GROSS H; FRIEDRICH G
    Strahlentherapie; 1964 Jun; 124():270-4. PubMed ID: 14249640
    [No Abstract]   [Full Text] [Related]  

  • 26. THE PHARMACOLOGY OF 3-PHENOXYPROPYLGUANIDINE.
    CHEN G; ENSOR CR; MCCARTHY DA; MCLEAN JR; CAMPBELL A
    J Pharmacol Exp Ther; 1964 Mar; 143():374-82. PubMed ID: 14161151
    [No Abstract]   [Full Text] [Related]  

  • 27. DISSOCIATION OF THE DECARBOXYLASE-INHIBITING AND NOREPINEPHRINE-DEPLETING EFFECTS OF ALPHA-METHYL-DOPA, ALPHA-ETHYL-DOPA, 4-BROMO-3-HYDROXY-BENZYLOXYAMINE AND RELATED SUBSTANCES.
    LEVINE RJ; SJOERDSMA A
    J Pharmacol Exp Ther; 1964 Oct; 146():42-7. PubMed ID: 14221224
    [No Abstract]   [Full Text] [Related]  

  • 28. [COMPARATIVE ACTION OF 2 DECARBOXYLASE INHIBITORS ON THE METABOLISM OF ENDOGENOUS AND EXOGENOUS 5-HYDROXYTRYPTAMINE].
    KUNZ E
    Arch Int Pharmacodyn Ther; 1964 Jan; 147():1-8. PubMed ID: 14116929
    [No Abstract]   [Full Text] [Related]  

  • 29. METABOLISM OF DOPA-14C IN THE NORMAL AND ALPHA-METHYLDOPATREATED MOUSE.
    WEISS B; ROSSI GV
    Biochem Pharmacol; 1963 Dec; 12():1399-405. PubMed ID: 14096427
    [No Abstract]   [Full Text] [Related]  

  • 30. ACTION OF ALPHA-METHYLDOPA ON THE PHARMACOLOGICAL AND BIOCHEMICAL EFFECT OF RESERPINE IN RATS AND MICE.
    PFEIFER AK; GALAMBOS E
    Biochem Pharmacol; 1965 Jan; 14():37-40. PubMed ID: 14286100
    [No Abstract]   [Full Text] [Related]  

  • 31. Norepinephrine reuptake inhibitors and risk of antihypertensive treatment intensification and major adverse cardiovascular events in patients with stable hypertension and depression.
    Desai R; Park H; Brown JD; Mohandas R; Smith SM
    Pharmacotherapy; 2022 Jun; 42(6):472-482. PubMed ID: 35478186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. THE CLINICAL PHARMACOLOGY OF POSTGANGLIONIC SYMPATHETIC BLOCKING AGENTS.
    ABRAMS WB; POCELINKO R; MOE RA; BATES H; HANAUER L; CAMACHO S
    Dis Chest; 1965 Aug; 48():178-86. PubMed ID: 14333651
    [No Abstract]   [Full Text] [Related]  

  • 33. ACTION OF GUANETHIDINE ON THE 5-HYDROXYTRYPTAMINE CONTENT OF THE BRAIN.
    FERRINI R; GLAESSER A
    J Pharm Pharmacol; 1963 Nov; 15():772-3. PubMed ID: 14079621
    [No Abstract]   [Full Text] [Related]  

  • 34. [STUDY ON THE CAROTID SINUS WALL NERVE DISCHARGE IN THE DOG].
    MIURA M
    Nihon Seirigaku Zasshi; 1964 Mar; 26():119-45. PubMed ID: 14143047
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis and activity of a new class of dual acting norepinephrine and serotonin reuptake inhibitors: 3-(1H-indol-1-yl)-3-arylpropan-1-amines.
    Mahaney PE; Vu AT; McComas CC; Zhang P; Nogle LM; Watts WL; Sarkahian A; Leventhal L; Sullivan NR; Uveges AJ; Trybulski EJ
    Bioorg Med Chem; 2006 Dec; 14(24):8455-66. PubMed ID: 16973367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BIOGENIC AMINES AND FECUNDITY OF TRIBOLIUM CONFUSUM DUVAL (COLEOPTERA).
    LEBLANC J; VILLENEUVE JL; LEMONDE A
    Can J Physiol Pharmacol; 1964 Nov; 42():757-62. PubMed ID: 14324207
    [No Abstract]   [Full Text] [Related]  

  • 37. [TRIALS OF A NEW ANTIHYPERTENSIVE, ALPHA-METHYL-DOPA (ALDOMET) WITH SPECIAL REFERENCE TO CHANGES IN RETINAL BLOOD FLOW].
    MIKUNI M; KIMURA S; TAKESHIMA M
    Rinsho Ganka; 1963 Nov; 17():1249-56. PubMed ID: 14095961
    [No Abstract]   [Full Text] [Related]  

  • 38. INHIBITION OF CEREBRAL DECARBOXYLASE AND BEHAVIOUR.
    PLETSCHER A; PRADAM DA; STEINER FA
    Int J Neuropharmacol; 1964 Dec; 3():550-64. PubMed ID: 14344493
    [No Abstract]   [Full Text] [Related]  

  • 39. [ALPHA,BETA,BETA-TRIMETHYLDOPA, A NEW INHIBITOR OF TRYPTOPHAN AND PHENYLALANINE HYDROXYLASE].
    BURKARD WP; GEY KF; PLETSCHER A
    Helv Physiol Pharmacol Acta; 1964 Oct; 64():C109-10. PubMed ID: 14246273
    [No Abstract]   [Full Text] [Related]  

  • 40. BEHAVIORAL EFFECTS OF L-ALPHA METHYL DOPA.
    RAY OS; BIVENS LW
    Life Sci (1962); 1965 Apr; 4():823-6. PubMed ID: 14343935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.